Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases.
Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics.
With approximately 7000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Zug, Switzerland and we have world-class manufacturing facilities in North Carolina and Denmark. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Follow us on social media – Twitter, LinkedIn, Facebook, YouTube.
Home | Biogen
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
ARSLA healthtech, Civic and Social Organizations | Other 5 Apr 2024 | | ||
1Health healthtech, Book and Periodical Publishing | Other 9 Apr 2024 | | ||
KCO Event Events Services | Other 1 Apr 2024 | | ||
Egualia – Industrie Farmaci Accessibili biotech, deeptech, Pharmaceutical Manufacturing | Other 3 Apr 2024 | | ||
APA de Géant, Maison Sport Santé healthtech, Wellness and Fitness Services | Other 2 Apr 2024 | | ||
Femmes de Santé healthtech, Wellness and Fitness Services | Other 4 Apr 2024 | | ||
Lys Therapeutics biotech, deeptech, Pharmaceutical Manufacturing | Other 22 Mar 2024 | | ||
Cumulus Neuroscience biotech, deeptech, healthtech, Biotechnology Research | Other 26 Feb 2024 | | ||
IRDI Capital Investissement Venture Capital and Private Equity Principals | Other 18 Mar 2024 | | ||
libheros healthtech, Hospitals and Health Care | Other 2 Mar 2024 | |